サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1697156

顔面神経麻痺の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Facial Palsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
顔面神経麻痺の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年03月31日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の顔面神経麻痺の市場規模は、2025年に25億米ドルになるとみられ、2025年～2032年の予測期間に4.5%のCAGRで拡大し、2032年には34億1,000万米ドルに達すると予測されています。

顔面神経麻痺は、顔面の筋肉に影響を及ぼす神経疾患で、多くの場合、神経損傷によって引き起こされる脱力や麻痺につながります。この疾患は、ベル麻痺、外傷、脳卒中、腫瘍、またはライム病などの感染症に起因することがあります。顔面神経麻痺市場には、薬物療法、理学療法、外科的介入、先進神経刺激装置などの治療オプションが含まれます。顔面神経障害の発生率の上昇は、診断および治療技術の進歩と相まって、市場成長の原動力となっています。同市場は、病院、専門クリニック、リハビリテーションセンター、在宅介護の現場に対応しており、患者の転帰を改善し、顔面機能を回復させるためのさまざまな治療法を提供しています。

世界の顔面神経麻痺市場は、神経疾患の有病率の上昇や、脳卒中に関連した顔面神経麻痺の影響を受けやすい高齢化人口の増加など、いくつかの重要な要因によって推進されています。早期診断と治療に対する意識の高まりと、神経移植、顔面再活性化手術、生体電子医学などの技術的進歩が相まって、市場の拡大に寄与しています。さらに、ボツリヌス毒素注射や再生医療アプローチなどの革新的な治療法が利用可能になったことで、治療効果と患者の満足度が高まっています。個別化医療や、言語療法や理学療法を含むリハビリテーション・プログラムへの注目の高まりが、市場の需要をさらに押し上げています。

有望な成長の見込みがあるにもかかわらず、顔面神経麻痺市場は、外科手術の高額な費用、熟練したヘルスケア専門家の限られた利用可能性、特定の地域における不十分な償還政策に関連する課題に直面しています。また、新しい治療法や医療機器に関連する規制上の課題も市場成長の妨げとなっています。さらに、顔面変形に関連する社会的烙印や心理的苦痛は、診断や治療の遅れにつながり、患者の転帰に影響を及ぼす可能性があります。このような課題に対処するためには、医療投資の拡大、政策改革、患者教育への取り組みが必要であり、顔面神経麻痺治療へのアクセスしやすさと手頃な価格を向上させる必要があります。

顔面神経麻痺市場は、神経刺激技術、再生療法、低侵襲手術技術の進歩によって大きな成長機会がもたらされます。幹細胞治療と遺伝子治療の開発は、神経再生と機能回復において計り知れない可能性を秘めています。さらに、遠隔医療やデジタルヘルス・ソリューションの導入が進むことで、遠隔地からの診察が容易になり、十分な治療を受けられない地域の患者が専門家による治療を受けられるようになります。研究機関、ヘルスケアプロバイダー、医療機器メーカーのコラボレーションは、イノベーションを加速し、市場拡大を促進することができます。AIを活用した診断ツールやリハビリテーション・プログラムへの投資は、患者管理や治療成果の改善にさらに貢献します。

当レポートでは、世界の顔面神経麻痺市場について調査し、診断別、治療別、最終用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値のある洞察

第4章 価格動向分析、2019年～2032年

第5章 世界の顔面麻痺市場の見通し

  • 主なハイライト
  • 市場規模の分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模分析と予測、2025年～2032年
  • 世界の顔面神経麻痺市場の見通し：診断別
    • イントロダクション/主な調査結果
    • 過去の市場規模と数量分析、診断別、2019年～2024年
    • 現在の市場規模と数量分析と予測、診断別、2025年～2032年
  • 市場の魅力分析：診断別
  • 世界の顔面麻痺市場の見通し：治療別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、治療別、2019年～2024年
    • 現在の市場規模分析と予測、治療別、2025年～2032年
  • 市場の魅力分析：治療
  • 世界の顔面麻痺市場の見通し：最終用途別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、最終用途別、2019年～2024年
    • 現在の市場規模分析と予測、最終用途別、2025年～2032年
  • 市場の魅力分析：最終用途別

第6章 世界の顔面麻痺市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模と数量（単位）分析、地域別、2019年～2024年
  • 現在の市場規模と数量（単位）分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第7章 北米の顔面神経麻痺市場の見通し

第8章 欧州の顔面麻痺市場の見通し

第9章 東アジアの顔面麻痺市場の見通し

第10章 南アジアおよびオセアニアの顔面麻痺市場の見通し

第11章 ラテンアメリカの顔面麻痺市場の見通し

第12章 中東・アフリカの顔面麻痺市場の見通し

第13章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Pfizer Inc.
    • Sanofi
    • Brainlab AG
    • GE Healthcare
    • GlaxoSmithKline plc
    • iTENS Australia
    • Johnson &Johnson Services, Inc.
    • MED-EL Medical Electronics
    • Medtronic plc
    • Natus Medical
    • Nihon Kohden Corporation
    • Novartis AG
    • Siemens Healthineers AG
    • TensCare Ltd.
    • Teva Pharmaceutical Industries Ltd.

第14章 付録

目次
Product Code: PMRREP35176

Persistence Market Research has recently released a comprehensive report on the worldwide market for facial palsy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global facial palsy market from 2025 to 2032.

Key Insights:

  • Facial Palsy Market Size (2025E): US$ 2.50 Bn
  • Projected Market Value (2032F): US$ 3.41 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.5%

Facial Palsy Market - Report Scope

Facial palsy is a neurological disorder that affects the facial muscles, leading to weakness or paralysis, often caused by nerve damage. The condition can result from Bell's palsy, trauma, stroke, tumors, or infections such as Lyme disease. The facial palsy market encompasses treatment options, including medications, physical therapy, surgical interventions, and advanced neurostimulation devices. The increasing incidence of facial nerve disorders, coupled with advancements in diagnostic and therapeutic technologies, is driving market growth. The market caters to hospitals, specialty clinics, rehabilitation centers, and homecare settings, offering a range of treatment modalities to improve patient outcomes and restore facial function.

Market Growth Drivers

The global facial palsy market is propelled by several key factors, including the rising prevalence of neurological disorders and the growing aging population, which is more susceptible to stroke-related facial paralysis. Increasing awareness about early diagnosis and treatment, coupled with technological advancements such as nerve grafting, facial reanimation surgery, and bioelectronic medicine, contributes to market expansion. Additionally, the availability of innovative therapies, including botulinum toxin injections and regenerative medicine approaches, enhances treatment efficacy and patient satisfaction. The growing focus on personalized medicine and rehabilitation programs, including speech and physiotherapy, further drives market demand.

Market Restraints

Despite promising growth prospects, the facial palsy market faces challenges related to the high cost of surgical procedures, limited availability of skilled healthcare professionals, and inadequate reimbursement policies in certain regions. Regulatory challenges associated with novel therapies and medical devices also hinder market growth. Furthermore, social stigma and psychological distress associated with facial deformities may lead to delayed diagnosis and treatment, affecting patient outcomes. Addressing these challenges requires increased healthcare investment, policy reforms, and patient education initiatives to enhance accessibility and affordability of facial palsy treatments.

Market Opportunities

The facial palsy market presents significant growth opportunities driven by advancements in neurostimulation technologies, regenerative therapies, and minimally invasive surgical techniques. The development of stem cell therapy and gene therapy holds immense potential in nerve regeneration and functional recovery. Additionally, the increasing adoption of telemedicine and digital health solutions facilitates remote consultation, improving access to expert care for patients in underserved regions. Collaborations between research institutions, healthcare providers, and medical device manufacturers can accelerate innovation and drive market expansion. Investments in AI-driven diagnostic tools and rehabilitation programs further contribute to improved patient management and treatment outcomes.

Key Questions Answered in the Report

  • What are the primary factors driving the growth of the facial palsy market globally?
  • Which treatment modalities and technologies are gaining traction in the facial palsy landscape?
  • How are technological advancements reshaping the competitive landscape of the facial palsy market?
  • Who are the key players contributing to the facial palsy market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global facial palsy market?

Competitive Intelligence and Business Strategy

Leading players in the global facial palsy market, including Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced neurostimulation devices, regenerative therapies, and minimally invasive surgical solutions. Collaborations with healthcare providers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving facial palsy treatment landscape.

Key Companies Profiled:

  • Medtronic Plc
  • Stryker Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ipsen S.A.
  • Revance Therapeutics Inc.
  • Checkpoint Surgical Inc.
  • Astellas Pharma Inc.
  • Medline Industries Inc.
  • BTL Industries Inc.

Facial Palsy Market Segmentation

By Diagnosis

  • Electromyography (EMG)
  • CT
  • MRI

By Treatment

  • Surgical
  • Non-Surgical

By End Use

  • Hospitals
  • Specialty Clinics

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Facial Palsy Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Diagnosis Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Diagnosis Prices
  • 4.3. Pricing Analysis By Diagnosis
  • 4.4. Regional Prices and Diagnosis Preferences

5. Global Facial Palsy Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Facial Palsy Market Outlook: Diagnosis
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Diagnosis, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
      • 5.3.3.1. Electromyography (EMG)
      • 5.3.3.2. CT
      • 5.3.3.3. MRI
  • 5.4. Market Attractiveness Analysis: Diagnosis
  • 5.5. Global Facial Palsy Market Outlook: Treatment
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Treatment, 2019-2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
      • 5.5.3.1. Surgical
      • 5.5.3.2. Non-Surgical
  • 5.6. Market Attractiveness Analysis: Treatment
  • 5.7. Global Facial Palsy Market Outlook: End Use
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2019-2024
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
      • 5.7.3.1. Hospitals
      • 5.7.3.2. Specialty Clinics
  • 5.8. Market Attractiveness Analysis: End Use

6. Global Facial Palsy Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Facial Palsy Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Diagnosis
    • 7.2.3. By Treatment
    • 7.2.4. By End Use
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 7.4.1. Electromyography (EMG)
    • 7.4.2. CT
    • 7.4.3. MRI
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 7.5.1. Surgical
    • 7.5.2. Non-Surgical
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
  • 7.7. Market Attractiveness Analysis

8. Europe Facial Palsy Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Diagnosis
    • 8.2.3. By Treatment
    • 8.2.4. By End Use
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 8.4.1. Electromyography (EMG)
    • 8.4.2. CT
    • 8.4.3. MRI
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 8.5.1. Surgical
    • 8.5.2. Non-Surgical
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
  • 8.7. Market Attractiveness Analysis

9. East Asia Facial Palsy Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Diagnosis
    • 9.2.3. By Treatment
    • 9.2.4. By End Use
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 9.4.1. Electromyography (EMG)
    • 9.4.2. CT
    • 9.4.3. MRI
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 9.5.1. Surgical
    • 9.5.2. Non-Surgical
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Facial Palsy Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Diagnosis
    • 10.2.3. By Treatment
    • 10.2.4. By End Use
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 10.4.1. Electromyography (EMG)
    • 10.4.2. CT
    • 10.4.3. MRI
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 10.5.1. Surgical
    • 10.5.2. Non-Surgical
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
  • 10.7. Market Attractiveness Analysis

11. Latin America Facial Palsy Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Diagnosis
    • 11.2.3. By Treatment
    • 11.2.4. By End Use
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 11.4.1. Electromyography (EMG)
    • 11.4.2. CT
    • 11.4.3. MRI
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 11.5.1. Surgical
    • 11.5.2. Non-Surgical
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Facial Palsy Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Diagnosis
    • 12.2.3. By Treatment
    • 12.2.4. By End Use
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Diagnosis, 2025-2032
    • 12.4.1. Electromyography (EMG)
    • 12.4.2. CT
    • 12.4.3. MRI
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 12.5.1. Surgical
    • 12.5.2. Non-Surgical
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Pfizer Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Diagnosis Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Sanofi
    • 13.3.3. Brainlab AG
    • 13.3.4. GE Healthcare
    • 13.3.5. GlaxoSmithKline plc
    • 13.3.6. iTENS Australia
    • 13.3.7. Johnson & Johnson Services, Inc.
    • 13.3.8. MED-EL Medical Electronics
    • 13.3.9. Medtronic plc
    • 13.3.10. Natus Medical
    • 13.3.11. Nihon Kohden Corporation
    • 13.3.12. Novartis AG
    • 13.3.13. Siemens Healthineers AG
    • 13.3.14. TensCare Ltd.
    • 13.3.15. Teva Pharmaceutical Industries Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations